Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update

Iovance Biotherapeutics (IOVA) Misses Q4 EPS by 9c

February 25, 2020 4:50 PM EST

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q4 EPS of ($0.50), $0.09 worse than the analyst estimate of ($0.41).

During 2019 we made tremendous progress in advancing Iovance TIL and PBL products, said Maria Fardis, Ph.D., MBA, Iovance President and Chief Executive Officer. We conducted two planned pivotal... More